BioFreedom US IDE Feasibility Trial
Study for patients with artery disease using drug coated coronary stent during cartheric cathererization
Sponsor: Biosensors Europe SA
Enrolling: Male and Female Patients
IRB Number: AAAO0759
U.S. Govt. ID: NCT02131142
Contact: Kumar Kalapatapu: 914-593-7800 / kk2816@cumc.columbia.edu
Additional Study Information: The purpose of this study is to evaluate the Biosensors BioFreedom Biolimus A9 Drug Coated Coronary Stent on people with coronary artery disease (blockages in the heart arteries) to determine if it is safe and effective.
This study is closed
Investigator
Kumar Kalapatapu, MD, FACC
Do You Qualify?
Do you have ischemic heart disease, stable or unstable angina? Yes No
Do you have a hypersensitivity or allergy to asprin, heparin or cloidogrel? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Kumar Kalapatapu
kk2816@cumc.columbia.edu
914-593-7800
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE